Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma.

Tania JainCraig S SauterGunjan L ShahMolly A MaloyJason ChanMichael ScordoScott T AvecillaYakup BatleviParastoo Bahrami DahiConnie W BatleviM Lia PalombaSergio A GiraltMiguel-Angel Perales

Published in: Leukemia (2019)

Keyphrases

stem cell transplantation
acute lymphoblastic leukemia
acute myeloid leukemia
bone marrow
diffuse large b cell lymphoma
multiple myeloma
hodgkin lymphoma
hematopoietic stem cell
stem cells
low dose
cell therapy
smoking cessation
replacement therapy